Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Patient Satisfaction With Belatacept Therapy: A Single-Center, Cross-Sectional Study
Abhinaya Sridhar
, Andrew Santeusanio
, Emily Rademacher
, Jonathan Armenti
,
Samira S. Farouk
Icahn School of Medicine at Mount Sinai
Institute for Medical Education
Medicine
Medicine - Nephrology
Nephrology T32
Recanati Miller Transplantation Institute
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Patient Satisfaction With Belatacept Therapy: A Single-Center, Cross-Sectional Study'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Patient Satisfaction
100%
Single Center
100%
Belatacept
100%
Satisfaction Index
33%
Kidney Transplantation
16%
Adverse Effects
16%
Clinical Follow-up
16%
Calcineurin Inhibitors
16%
Kidney Transplant
16%
High-score
16%
Kidney Transplant Recipients
16%
Treatment Satisfaction
16%
Overall Satisfaction
16%
Maintenance Immunosuppression
16%
Everyday Life
16%
Infusion Center
16%
Single Health System
16%
Medicine and Dentistry
Cross Sectional Study
100%
Patient Satisfaction
100%
Belatacept
100%
Infusion
50%
Kidney Graft
33%
Kidney Transplantation
16%
Immunosuppressive Treatment
16%
Calcineurin Inhibitor
16%
Health System
16%
Adverse Effect
16%
Side Effect
16%
Nursing and Health Professions
Patient Satisfaction
100%
Belatacept
100%
Cross-Sectional Study
100%
Infusion
50%
Kidney Graft
33%
Immunosuppressive Treatment
16%
Kidney Transplantation
16%
Calcineurin Inhibitor
16%
Efficacy
16%
Side Effect
16%